Jazz Pharmaceuticals (JAZZ) EVP Iannone reports RSU tax-withholding share disposition

Rhea-AI Filing Summary

Jazz Pharmaceuticals EVP and CMO Robert Iannone reported a routine tax-related share disposition. On vesting of previously granted restricted stock units, 3,764 Ordinary Shares were withheld to satisfy tax obligations at $237.72 per share. After this withholding, he directly holds 85,107 Ordinary Shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Iannone Robert

Role EVP, Global Head of R&D & CMO

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares	3,764	$237.72	$895K

Holdings After Transaction: Ordinary Shares — 85,107 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 3,764 shares Tax valuation price: $237.72 per share Shares held after transaction: 85,107 shares

3 metrics

Shares withheld for taxes 3,764 shares Tax-withholding disposition on RSU vesting

Tax valuation price $237.72 per share Value used for withheld Ordinary Shares

Shares held after transaction 85,107 shares Direct ownership following tax withholding

Key Terms

restricted stock units, tax obligations, tax-withholding disposition

3 terms

restricted stock units financial

"vesting of a portion of previously granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Shares withheld to satisfy tax obligations arising out of vesting"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 06:17 PM Accepted by SEC EDGAR 07/02/2026 - 06:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Iannone Robert

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Head of R&D & CMO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/30/2026		F(1)		3,764	D	$237.72	85,107	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Robert Iannone	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Robert Iannone?

Jazz Pharmaceuticals reported that EVP and CMO Robert Iannone had 3,764 Ordinary Shares withheld to cover tax obligations from vesting restricted stock units. This was a tax-withholding disposition, not an open-market purchase or sale of shares.

How many Jazz Pharmaceuticals (JAZZ) shares were withheld for taxes in this Form 4?

A total of 3,764 Jazz Pharmaceuticals Ordinary Shares were withheld to satisfy tax obligations. The withholding occurred in connection with the vesting of a portion of previously granted restricted stock units, according to the Form 4 footnote disclosure.

At what price were the withheld Jazz Pharmaceuticals (JAZZ) shares valued?

The withheld Jazz Pharmaceuticals Ordinary Shares were valued at $237.72 per share. This price is used for calculating the tax-withholding disposition related to the vesting of previously granted restricted stock units as reported in the Form 4 filing.

How many Jazz Pharmaceuticals (JAZZ) shares does Robert Iannone hold after this transaction?

Following the tax-withholding disposition, Robert Iannone directly holds 85,107 Jazz Pharmaceuticals Ordinary Shares. This figure reflects his post-transaction ownership as reported in the Form 4 and shows his remaining equity stake after the RSU-related withholding.

Was the Jazz Pharmaceuticals (JAZZ) Form 4 transaction an open-market sale or a tax event?

The Form 4 transaction was a tax event, not an open-market sale. Shares were withheld to satisfy tax obligations arising from vesting restricted stock units, classified as a tax-withholding disposition rather than a discretionary buy or sell in the market.